BORON Molecular, a company wholly owned by Western Australian listed biotechnology investment company Xceed Biotechnology, has been granted a US and European Patent.
WA-BASED business angel Churchill Capital has helped Victorian-based Boron Molecular complete a $1.9 million capital raising ahead of a planned Australian Stock Exchange listing for the pharmaceutical player in the first half of this year.
